Effect of empagliflozin on left ventricular volumes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF)

Citation
Lee MMY, Brooksbank KJM, Wetherall K, et al. Circulation 2020; epub ahead of press.